Roles of PAR1 and PAR2 in viral myocarditis

Schultheiss, 2011, The management of myocarditis, Eur Heart J, 32, 2616, 10.1093/eurheartj/ehr165 Blauwet, 2010, Myocarditis, Prog Cardiovasc Dis, 52, 274, 10.1016/j.pcad.2009.11.006 Antoniak, 2008, Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity, J Mol Cell Cardiol, 45, 118, 10.1016/j.yjmcc.2008.03.013 Antoniak, 2014, Coagulation, Protease-Activated Receptors, and Viral Myocarditis, J Cardiovasc Transl Res, 7, 203, 10.1007/s12265-013-9515-7 Thompson, 2008, Toll-like receptors regulation of viral infection and disease, Adv Drug Deliv Rev, 60, 786, 10.1016/j.addr.2007.11.003 Koyama, 2008, Innate immune response to viral infection, Cytokine, 43, 336, 10.1016/j.cyto.2008.07.009 Kemball, 2010, Type B coxsackieviruses and their interactions with the innate and adaptive immune systems, Future Microbiol, 5, 1329, 10.2217/fmb.10.101 Huber, 2008, Host immune responses to coxsackievirus B3, Curr Top Microbiol Immunol, 323, 199 Abston, 2012, Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease, Clin Dev Immunol, 2012, 129486, 10.1155/2012/129486 Riad, 2011, TRIF is a critical survival factor in viral cardiomyopathy, J Immunol, 186, 2561, 10.4049/jimmunol.1002029 Wessely, 2001, Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication, Circulation, 103, 756, 10.1161/01.CIR.103.5.756 Deonarain, 2004, Protective role for interferon-beta in coxsackievirus B3 infection, Circulation, 110, 3540, 10.1161/01.CIR.0000136824.73458.20 Stewart, 2005, Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response, J Virol, 79, 2979, 10.1128/JVI.79.5.2979-2987.2005 Godeny, 1987, Murine natural killer cells limit coxsackievirus B3 replication, J Immunol, 139, 913, 10.4049/jimmunol.139.3.913 Coughlin, 2000, Thrombin signalling and protease-activated receptors, Nature, 407, 258, 10.1038/35025229 Nakanishi-Matsui, 2000, PAR3 is a cofactor for PAR4 activation by thrombin, Nature, 404, 609, 10.1038/35007085 Antoniak, 2011, Protease-activated receptors and myocardial infarction, IUBMB Life, 63, 383, 10.1002/iub.441 Shpacovitch, 2007, Protease-activated receptors: novel PARtners in innate immunity, Trends Immunol, 28, 541, 10.1016/j.it.2007.09.001 Moretti, 2008, The contribution of PARs to inflammation and immunity to fungi, Mucosal Immunol, 1, 156, 10.1038/mi.2007.13 Rallabhandi, 2008, Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity, J Biol Chem, 283, 24314, 10.1074/jbc.M804800200 Weithauser, 2013, Protease-activated receptor 2 regulates the Innate Immune Response to Viral Infection in a CVB3-induced Myocarditis, J Am Coll Cardiol, 62, 1737, 10.1016/j.jacc.2013.05.076 Nhu, 2012, Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages, Innate Immun, 18, 193, 10.1177/1753425910395044 Nhu, 2010, Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo, Mucosal Immunol, 3, 29, 10.1038/mi.2009.120 Khoufache, 2009, Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway, J Immunol, 182, 7795, 10.4049/jimmunol.0803743 Chignard, 2006, Neutrophil and pathogen proteinases versus proteinase-activated receptor-2 lung epithelial cells: more terminators than activators, Am J Respir Cell Mol Biol, 34, 394, 10.1165/rcmb.2005-0250TR Lazo, 2011, Interference with p53 functions in human viral infections, a target for novel antiviral strategies?, Rev Med Virol, 21, 285 Antoniak, 2013, PAR-1 contributes to the innate immune response during viral infection, J Clin Invest, 123, 1310, 10.1172/JCI66125 Takaoka, 2003, Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence, Nature, 424, 516, 10.1038/nature01850 Suzuki, 2009, Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway, Am J Respir Cell Mol Biol, 41, 742, 10.1165/rcmb.2008-0157OC Hwang, 2007, Coxsackievirus B3 modulates cell death by downregulating activating transcription factor 3 in HeLa cells, Virus Res, 130, 10, 10.1016/j.virusres.2007.05.007 Munoz-Fontela, 2008, Transcriptional role of p53 in interferon-mediated antiviral immunity, J Exp Med, 205, 1929, 10.1084/jem.20080383 Vemuri, 1996, Thrombin stimulates wortmannin-inhibitable phosphoinositide 3-kinase and membrane blebbing in CHRF-288 cells, Biochem J, 314, 805, 10.1042/bj3140805